4DMedical Limited (4DX.AX)
AUD 0.46
(1.11%)
AUD 0.46
(1.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -27.96 Million AUD | 10.16% |
| 2023 | -31.13 Million AUD | 15.29% |
| 2022 | -36.75 Million AUD | -95.71% |
| 2021 | -18.77 Million AUD | -17.64% |
| 2020 | -15.96 Million AUD | -127.46% |
| 2019 | -7.01 Million AUD | -35.64% |
| 2018 | -5.17 Million AUD | -10.57% |
| 2017 | -4.67 Million AUD | -447.32% |
| 2016 | -854.86 Thousand AUD | -348.64% |
| 2015 | -190.54 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -48.22 Million AUD | -54.91% |
| 2024 Q1 | -11.77 Million AUD | 47.22% |
| 2024 Q4 | -7.3 Million AUD | 0.0% |
| 2024 Q2 | -23.55 Million AUD | -100.0% |
| 2024 Q3 | -7.3 Million AUD | 69.0% |
| 2023 Q3 | -11.15 Million AUD | 49.86% |
| 2023 FY | -31.13 Million AUD | 15.29% |
| 2023 Q1 | -11.12 Million AUD | 43.45% |
| 2023 Q4 | -22.31 Million AUD | -100.0% |
| 2023 Q2 | -22.25 Million AUD | -100.0% |
| 2022 Q1 | -8.53 Million AUD | 32.86% |
| 2022 Q2 | -17.07 Million AUD | -100.0% |
| 2022 Q4 | -19.67 Million AUD | -100.0% |
| 2022 FY | -36.75 Million AUD | -95.71% |
| 2022 Q3 | -9.83 Million AUD | 42.37% |
| 2021 Q3 | -6.35 Million AUD | 45.31% |
| 2021 FY | -18.77 Million AUD | -17.64% |
| 2021 Q2 | -11.62 Million AUD | -100.0% |
| 2021 Q1 | -5.81 Million AUD | 43.68% |
| 2021 Q4 | -12.71 Million AUD | -100.0% |
| 2020 Q1 | -2.66 Million AUD | -30.09% |
| 2020 Q3 | -5.31 Million AUD | 0.38% |
| 2020 Q4 | -10.31 Million AUD | -94.19% |
| 2020 FY | -15.96 Million AUD | -127.46% |
| 2020 Q2 | -5.33 Million AUD | -100.0% |
| 2019 Q4 | -2.05 Million AUD | 0.0% |
| 2019 Q2 | -1.45 Million AUD | 0.0% |
| 2019 Q1 | -1.45 Million AUD | 0.0% |
| 2019 FY | -7.01 Million AUD | -35.64% |
| 2019 Q3 | -2.05 Million AUD | -40.57% |
| 2018 FY | -5.17 Million AUD | -10.57% |
| 2017 FY | -4.67 Million AUD | -447.32% |
| 2016 FY | -854.86 Thousand AUD | -348.64% |
| 2015 FY | -190.54 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Adherium Limited | -11.98 Million AUD | -133.338% |
| Aroa Biosurgery Limited | -9.78 Million AUD | -185.728% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -541.211% |
| Anteris Technologies Ltd | -66.63 Million AUD | 58.029% |
| Control Bionics Limited | -5.92 Million AUD | -371.665% |
| CardieX Limited | -4.63 Million AUD | -503.539% |
| Compumedics Limited | -269 Thousand AUD | -10296.379% |
| Cochlear Limited | 521.5 Million AUD | 105.363% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -480.94% |
| Cyclopharm Limited | -9.22 Million AUD | -203.168% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -1632.291% |
| Nova Eye Medical Limited | -3.79 Million AUD | -636.536% |
| HeraMED Limited | -6.42 Million AUD | -335.07% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | -59.122% |
| ImpediMed Limited | -19.03 Million AUD | -46.912% |
| InhaleRx Limited | -1.38 Million AUD | -1917.059% |
| LBT Innovations Limited | -4.74 Million AUD | -490.005% |
| Micro-X Limited | -13.02 Million AUD | -114.679% |
| Neurotech International Limited | -5.58 Million AUD | -400.757% |
| OncoSil Medical Limited | -11.98 Million AUD | -133.359% |
| PolyNovo Limited | 1.16 Million AUD | 2504.666% |
| Respiri Limited | -7 Million AUD | -299.507% |
| SomnoMed Limited | -3.84 Million AUD | -628.042% |
| Universal Biosensors, Inc. | -16.68 Million AUD | -67.66% |
| Uscom Limited | -2.4 Million AUD | -1063.153% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | -377.719% |